2024-04-13 08:15:00 ET
Summary
- Medtronic is a healthcare technology company that has seen encouraging growth in the current fiscal year.
- The company has maintained pricing power and has a strong balance sheet, with an A+ grade for profitability.
- Medtronic is well-positioned for future opportunities, including diabetes care, and is undervalued compared to historical norms with a decent starting dividend yield.
Buying quality companies at reasonable prices remains a winning investment strategy in my opinion despite all the noise around high-flying Al names on the market today. What's even better is if those stocks pay you a decent yield for holding onto them, which makes natural price volatility easier to bear....
Read the full article on Seeking Alpha
For further details see:
Medtronic: Dividend Aristocrat Value In Plain Sight